AdaptHealth Corp. reports developments tied to its healthcare-at-home business, which provides home medical equipment, medical supplies and related services. The company’s updates commonly address its Sleep Health, Respiratory Health, Diabetes Health and Wellness at Home categories, including sleep therapy equipment and supplies for obstructive sleep apnea, respiratory services, diabetes-related supplies and in-home wellness offerings.
Recurring AdaptHealth news also covers quarterly and annual results, financial guidance, patient census trends, digital patient engagement through myApp, referral and payor relationships, capitated partnerships, acquisitions and dispositions, credit facility activity, debt ratings and investor conference participation. The company serves Medicare, Medicaid and commercial insurance beneficiaries through a national operating network.
AdaptHealth Corp. (NASDAQ: AHCO), a leader in healthcare-at-home solutions, announced its participation in the UBS Healthcare Services Cape Cod Summit on June 4, 2024. AdaptHealth provides a range of home medical equipment and services, including sleep therapy, diabetes treatment, and chronic therapy services. The company supports 4.1 million patients annually in all 50 states through a network of 680 locations in 47 states. AdaptHealth partners with a diverse network of referral sources such as hospitals, clinics, and skilled nursing facilities.
AdaptHealth Corp. (NASDAQ: AHCO) announced the grant of restricted stock units (RSUs) to Suzanne Foster, the newly appointed CEO, as an inducement under Nasdaq Listing Rule 5635(c)(4). The grant, approved by the Compensation Committee on May 11, 2024, covers 553,251 shares of common stock at target performance levels. The RSUs vest in three tranches: 229,740 shares over three years starting May 20, 2025, 93,771 shares over two years starting the same date, and the remaining shares based on the Total Shareholder Return (TSR) over a three-year period. The vesting depends on Ms. Foster's continued service with AdaptHealth. The company provides home medical equipment and services, reaching 4.1 million patients annually across 670 locations in 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) will participate in the 2024 Leerink Partners Healthcare Crossroads Conference in Austin on May 29, 2024, with a fireside chat at 3:00 PM CT. AdaptHealth is a national provider of patient-centered healthcare-at-home solutions, including home medical equipment, supplies, and related services. Their services cater to patients with chronic conditions, offering sleep therapy equipment, diabetes treatment devices, and other home medical equipment. The company reaches approximately 4.1 million patients annually across all 50 states through 680 locations in 47 states. A webcast link for the event will be available on the company's website under 'Investor Relations'.
AdaptHealth Corp. will participate in the BofA Securities 2024 Health Care Conference, with key executives engaging in a fireside chat. The Company offers patient-centered healthcare-at-home solutions, catering to over 4.1 million patients annually in all 50 states. AdaptHealth provides a wide range of medical products and services, including sleep therapy equipment, diabetes treatment supplies, HME devices, oxygen therapy, and other related services.
AdaptHealth Corp. announced financial results for the first quarter ended March 31, 2024. Net revenue increased by 6.4% to $792.5 million. However, net loss was $2.1 million compared to net income of $15.7 million in the same period last year. Adjusted EBITDA increased by 18.3% to $158.5 million. Cash flow from operations decreased to $49.0 million, and Free Cash Flow decreased to $(38.9) million due to delayed payments from the Change Healthcare data breach.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.